國家衛生研究院 NHRI:Item 3990099045/3785
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 859787      Online Users : 829
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
    •  Adv. Search
    Home ‧ Login ‧ Upload ‧ Help ‧ About ‧ Administer Goto mobile version


    Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/3785


    Title: The mechanism of the actions of oxaliplatin on ion currents and action potentials in differentiated NG108-15 neuronal cells
    Authors: Wu, SN;Chen, BS;Wu, YH;Peng, H;Chen, LT
    Contributors: National Institute of Cancer Research
    Abstract: Oxaliplatin (OXAL) is a platinum-based chemotherapeutic agent which is effective against advanced or metastatic gastrointestinal cancer. However, the mechanisms responsible for the development of the neuropathy induced by this agent remain unclear. In this study, we attempted to evaluate the possible effects of OXAL on ion currents and action potentials (APs) in NG108-15 cells differentiated with dibutyryl cyclic-AMP. Application of OXAL decreased the peak amplitude of voltage-gated Na+ current (INa) with no change in the overall current-voltage relations of the currents. This agent also produced a concentration-dependent slowing of INa inactivation. A further application of ranolazine reversed OXAL-induced slowing of INa inactivation. Unlike ranolazine or riluzole, OXAL had no effect on persistent INa elicited by long ramp pulses. OXAL (100 μM) also had little or no effect on the peak amplitude of L-type Ca2+ currents in NG108-15 cells, while it suppressed delayed-rectifier K+ current. In current-clamp recordings, OXAL alone reduced the amplitude of APs; however, it did not alter the duration of APs. However, after application of tefluthrin, OXAL did increase the duration of APs. Moreover, OXAL decreased the peak amplitude of INa with a concomitant reduction of current inactivation in HEK293T cells expressing SCN5A. The effects of OXAL on ion currents presented here may contribute to its neurotoxic actions in vivo.
    Date: 2009-07
    Relation: NeuroToxicology. 2009 Jul;30(4):677-685.
    Link to: http://dx.doi.org/10.1016/j.neuro.2009.04.010
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0161-813X&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000268834700021
    Cited Times(Scopus): http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=67651001970
    Appears in Collections:[Li-Tzong Chen] Periodical Articles

    Files in This Item:

    File Description SizeFormat
    SCP67651001970.pdf543KbAdobe PDF690View/Open


    All items in NHRI are protected by copyright, with all rights reserved.

    Related Items in TAIR

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback